A group led by the Department of Neurosurgery, Brain Research Institute, Niigata University, has succeeded in the diagnosis of leptomeningeal disease in diffuse midline gliomas by detecting ...

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus, and spinal ...

Modeyso's approval offers a new treatment for diffuse midline glioma with H3 K27M mutation, a previously untreatable condition beyond radiation. The drug is well-tolerated, with minimal side effects, ...

The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains. The accelerated approval from the U.S. Food and Drug ...

Dordaviprone is the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma, targeting an ultra-rare brain tumor in children and young adults. The approval was based on a 22% ...

Each year, approximately 200 to 300 children in the United States are diagnosed with diffuse midline gliomas (DMG), a tumor that begins in the brain or spinal cord. The tumors cannot be removed ...

Credit: Jazz Pharmaceuticals. Modeyso is the first FDA-approved treatment for this rare brain tumor. Continued approval for this indication is contingent upon verification of clinical benefit in the ...

Tumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying cancer-typical alterations. Physicians and cancer researchers have now ...

Kelley Mack’s death at 33 is putting glioma under the spotlight. After news broke that The Walking Dead and 9-1-1 star had died on Saturday, August 2, fans were reminded that the actress was recently ...